Report Detail

Request for Sample of this report

Other Global Oral Antidiabetic Agents Market 2024 by Company, Regions, Type and Application, Forecast to 2030

  • RnM3624854
    • |
  • 12 June, 2024
    • |
  • Global
    • |
  • 112 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Other

According to our (Global Info Research) latest study, the global Oral Antidiabetic Agents market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Oral Antidiabetic Agents refer to the oral drugs used to treat type 2 diabetes in patients who uncontrolled by diet and exercise. Currently, there are five distinct classes of hypoglycemic agents available include sulfonylureas, meglitinides, biguanides, thiazolidinediones and alpha-glucosidase inhibitors.
The Global Info Research report includes an overview of the development of the Oral Antidiabetic Agents industry chain, the market status of Home Use (Sulfonylureas, Meglitinides), Medical Institutions (Sulfonylureas, Meglitinides), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Oral Antidiabetic Agents.
Regionally, the report analyzes the Oral Antidiabetic Agents markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Oral Antidiabetic Agents market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Oral Antidiabetic Agents market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Oral Antidiabetic Agents industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Sulfonylureas, Meglitinides).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Oral Antidiabetic Agents market.
Regional Analysis: The report involves examining the Oral Antidiabetic Agents market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Oral Antidiabetic Agents market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Oral Antidiabetic Agents:
Company Analysis: Report covers individual Oral Antidiabetic Agents players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Oral Antidiabetic Agents This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Home Use, Medical Institutions).
Technology Analysis: Report covers specific technologies relevant to Oral Antidiabetic Agents. It assesses the current state, advancements, and potential future developments in Oral Antidiabetic Agents areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Oral Antidiabetic Agents market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Oral Antidiabetic Agents market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Sulfonylureas
Meglitinides
Biguanides
Thiazolidinediones
Alpha-glucosidase Inhibitors
Market segment by Application
Home Use
Medical Institutions
Others
Market segment by players, this report covers
Novo Nordisk
Eli Lilly
Sanofi
Roche
Teva
AstraZeneca
Wockhardt UK
Merck
Pfizer
Cipla
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Oral Antidiabetic Agents product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Oral Antidiabetic Agents, with revenue, gross margin and global market share of Oral Antidiabetic Agents from 2019 to 2024.
Chapter 3, the Oral Antidiabetic Agents competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Oral Antidiabetic Agents market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Oral Antidiabetic Agents.
Chapter 13, to describe Oral Antidiabetic Agents research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Oral Antidiabetic Agents
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Oral Antidiabetic Agents by Type
    • 1.3.1 Overview: Global Oral Antidiabetic Agents Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global Oral Antidiabetic Agents Consumption Value Market Share by Type in 2023
    • 1.3.3 Sulfonylureas
    • 1.3.4 Meglitinides
    • 1.3.5 Biguanides
    • 1.3.6 Thiazolidinediones
    • 1.3.7 Alpha-glucosidase Inhibitors
  • 1.4 Global Oral Antidiabetic Agents Market by Application
    • 1.4.1 Overview: Global Oral Antidiabetic Agents Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Home Use
    • 1.4.3 Medical Institutions
    • 1.4.4 Others
  • 1.5 Global Oral Antidiabetic Agents Market Size & Forecast
  • 1.6 Global Oral Antidiabetic Agents Market Size and Forecast by Region
    • 1.6.1 Global Oral Antidiabetic Agents Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global Oral Antidiabetic Agents Market Size by Region, (2019-2030)
    • 1.6.3 North America Oral Antidiabetic Agents Market Size and Prospect (2019-2030)
    • 1.6.4 Europe Oral Antidiabetic Agents Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific Oral Antidiabetic Agents Market Size and Prospect (2019-2030)
    • 1.6.6 South America Oral Antidiabetic Agents Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East and Africa Oral Antidiabetic Agents Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 Novo Nordisk
    • 2.1.1 Novo Nordisk Details
    • 2.1.2 Novo Nordisk Major Business
    • 2.1.3 Novo Nordisk Oral Antidiabetic Agents Product and Solutions
    • 2.1.4 Novo Nordisk Oral Antidiabetic Agents Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Novo Nordisk Recent Developments and Future Plans
  • 2.2 Eli Lilly
    • 2.2.1 Eli Lilly Details
    • 2.2.2 Eli Lilly Major Business
    • 2.2.3 Eli Lilly Oral Antidiabetic Agents Product and Solutions
    • 2.2.4 Eli Lilly Oral Antidiabetic Agents Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Eli Lilly Recent Developments and Future Plans
  • 2.3 Sanofi
    • 2.3.1 Sanofi Details
    • 2.3.2 Sanofi Major Business
    • 2.3.3 Sanofi Oral Antidiabetic Agents Product and Solutions
    • 2.3.4 Sanofi Oral Antidiabetic Agents Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Sanofi Recent Developments and Future Plans
  • 2.4 Roche
    • 2.4.1 Roche Details
    • 2.4.2 Roche Major Business
    • 2.4.3 Roche Oral Antidiabetic Agents Product and Solutions
    • 2.4.4 Roche Oral Antidiabetic Agents Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Roche Recent Developments and Future Plans
  • 2.5 Teva
    • 2.5.1 Teva Details
    • 2.5.2 Teva Major Business
    • 2.5.3 Teva Oral Antidiabetic Agents Product and Solutions
    • 2.5.4 Teva Oral Antidiabetic Agents Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Teva Recent Developments and Future Plans
  • 2.6 AstraZeneca
    • 2.6.1 AstraZeneca Details
    • 2.6.2 AstraZeneca Major Business
    • 2.6.3 AstraZeneca Oral Antidiabetic Agents Product and Solutions
    • 2.6.4 AstraZeneca Oral Antidiabetic Agents Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 AstraZeneca Recent Developments and Future Plans
  • 2.7 Wockhardt UK
    • 2.7.1 Wockhardt UK Details
    • 2.7.2 Wockhardt UK Major Business
    • 2.7.3 Wockhardt UK Oral Antidiabetic Agents Product and Solutions
    • 2.7.4 Wockhardt UK Oral Antidiabetic Agents Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Wockhardt UK Recent Developments and Future Plans
  • 2.8 Merck
    • 2.8.1 Merck Details
    • 2.8.2 Merck Major Business
    • 2.8.3 Merck Oral Antidiabetic Agents Product and Solutions
    • 2.8.4 Merck Oral Antidiabetic Agents Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Merck Recent Developments and Future Plans
  • 2.9 Pfizer
    • 2.9.1 Pfizer Details
    • 2.9.2 Pfizer Major Business
    • 2.9.3 Pfizer Oral Antidiabetic Agents Product and Solutions
    • 2.9.4 Pfizer Oral Antidiabetic Agents Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Pfizer Recent Developments and Future Plans
  • 2.10 Cipla
    • 2.10.1 Cipla Details
    • 2.10.2 Cipla Major Business
    • 2.10.3 Cipla Oral Antidiabetic Agents Product and Solutions
    • 2.10.4 Cipla Oral Antidiabetic Agents Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Cipla Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Oral Antidiabetic Agents Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of Oral Antidiabetic Agents by Company Revenue
    • 3.2.2 Top 3 Oral Antidiabetic Agents Players Market Share in 2023
    • 3.2.3 Top 6 Oral Antidiabetic Agents Players Market Share in 2023
  • 3.3 Oral Antidiabetic Agents Market: Overall Company Footprint Analysis
    • 3.3.1 Oral Antidiabetic Agents Market: Region Footprint
    • 3.3.2 Oral Antidiabetic Agents Market: Company Product Type Footprint
    • 3.3.3 Oral Antidiabetic Agents Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Oral Antidiabetic Agents Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global Oral Antidiabetic Agents Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global Oral Antidiabetic Agents Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global Oral Antidiabetic Agents Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America Oral Antidiabetic Agents Consumption Value by Type (2019-2030)
  • 6.2 North America Oral Antidiabetic Agents Consumption Value by Application (2019-2030)
  • 6.3 North America Oral Antidiabetic Agents Market Size by Country
    • 6.3.1 North America Oral Antidiabetic Agents Consumption Value by Country (2019-2030)
    • 6.3.2 United States Oral Antidiabetic Agents Market Size and Forecast (2019-2030)
    • 6.3.3 Canada Oral Antidiabetic Agents Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico Oral Antidiabetic Agents Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe Oral Antidiabetic Agents Consumption Value by Type (2019-2030)
  • 7.2 Europe Oral Antidiabetic Agents Consumption Value by Application (2019-2030)
  • 7.3 Europe Oral Antidiabetic Agents Market Size by Country
    • 7.3.1 Europe Oral Antidiabetic Agents Consumption Value by Country (2019-2030)
    • 7.3.2 Germany Oral Antidiabetic Agents Market Size and Forecast (2019-2030)
    • 7.3.3 France Oral Antidiabetic Agents Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom Oral Antidiabetic Agents Market Size and Forecast (2019-2030)
    • 7.3.5 Russia Oral Antidiabetic Agents Market Size and Forecast (2019-2030)
    • 7.3.6 Italy Oral Antidiabetic Agents Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific Oral Antidiabetic Agents Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific Oral Antidiabetic Agents Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific Oral Antidiabetic Agents Market Size by Region
    • 8.3.1 Asia-Pacific Oral Antidiabetic Agents Consumption Value by Region (2019-2030)
    • 8.3.2 China Oral Antidiabetic Agents Market Size and Forecast (2019-2030)
    • 8.3.3 Japan Oral Antidiabetic Agents Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea Oral Antidiabetic Agents Market Size and Forecast (2019-2030)
    • 8.3.5 India Oral Antidiabetic Agents Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia Oral Antidiabetic Agents Market Size and Forecast (2019-2030)
    • 8.3.7 Australia Oral Antidiabetic Agents Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America Oral Antidiabetic Agents Consumption Value by Type (2019-2030)
  • 9.2 South America Oral Antidiabetic Agents Consumption Value by Application (2019-2030)
  • 9.3 South America Oral Antidiabetic Agents Market Size by Country
    • 9.3.1 South America Oral Antidiabetic Agents Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil Oral Antidiabetic Agents Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina Oral Antidiabetic Agents Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa Oral Antidiabetic Agents Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa Oral Antidiabetic Agents Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa Oral Antidiabetic Agents Market Size by Country
    • 10.3.1 Middle East & Africa Oral Antidiabetic Agents Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey Oral Antidiabetic Agents Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia Oral Antidiabetic Agents Market Size and Forecast (2019-2030)
    • 10.3.4 UAE Oral Antidiabetic Agents Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 Oral Antidiabetic Agents Market Drivers
  • 11.2 Oral Antidiabetic Agents Market Restraints
  • 11.3 Oral Antidiabetic Agents Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Oral Antidiabetic Agents Industry Chain
  • 12.2 Oral Antidiabetic Agents Upstream Analysis
  • 12.3 Oral Antidiabetic Agents Midstream Analysis
  • 12.4 Oral Antidiabetic Agents Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Oral Antidiabetic Agents. Industry analysis & Market Report on Oral Antidiabetic Agents is a syndicated market report, published as Global Oral Antidiabetic Agents Market 2024 by Company, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Oral Antidiabetic Agents market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo